INNV InnovAge Holding Corp.
Stock · NasdaqGS · United States · Healthcare · US45784A1043
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by InnovAge Holding Corp., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 06 Nov 2026 21:07. Information, not advice.
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 02 Feb 2027 16:00 | 0.09 | — | — | Upcoming |
| 03 Nov 2026 16:00 | 0.09 | 0.17 | +88.6% | Beat |
| 08 Sep 2026 16:00 | 0.08 | 0.10 | +29.3% | Beat |
| 05 May 2026 16:00 | 0.05 | 0.17 | +246.4% | Beat |
| 03 Feb 2026 16:00 | 0.04 | 0.10 | +144.0% | Beat |
| 04 Nov 2025 16:00 | 0.04 | 0.07 | +74.5% | Beat |
| 09 Sep 2025 16:00 | 0.01 | 0.07 | +596.0% | Beat |
| 06 May 2025 16:00 | — | 0.02 | — | — |
| 04 Feb 2025 16:00 | — | -0.01 | — | — |
| 05 Nov 2024 16:00 | -0.01 | -0.02 | -85.0% | Miss |
| 10 Sep 2024 16:00 | -0.02 | -0.01 | +50.9% | Beat |
| 07 May 2024 16:00 | -0.03 | -0.04 | -14.4% | Miss |
| 06 Feb 2024 16:00 | -0.02 | 0.01 | +133.6% | Beat |
| 07 Nov 2023 16:00 | -0.04 | -0.08 | -117.2% | Miss |
| 12 Sep 2023 16:00 | -0.04 | -0.09 | -155.2% | Miss |
| 09 May 2023 16:00 | -0.05 | -0.05 | -6.8% | Miss |
| 07 Feb 2023 16:00 | -0.09 | -0.07 | +25.5% | Beat |
| 08 Nov 2022 16:00 | — | -0.05 | -2,560.0% | Miss |
| 13 Sep 2022 16:00 | 0.01 | -0.04 | -960.0% | Miss |
| 10 May 2022 16:00 | 0.06 | -0.01 | -115.2% | Miss |
| 09 Feb 2022 16:00 | 0.07 | 0.04 | -43.1% | Miss |
| 09 Nov 2021 16:00 | 0.05 | 0.07 | +34.1% | Beat |
| 21 Sep 2021 16:00 | 0.07 | 0.07 | -4.5% | Miss |
| 10 May 2021 16:00 | -0.07 | 0.07 | +202.7% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2026 | 989.7M | +15.9% | -2.5M | -0.3% | — | — | 50.4M |
| 2025 | 853.7M | +11.8% | -30.3M | -3.6% | — | — | 26.6M |
| 2024 | 763.9M | +11.0% | -21.3M | -2.8% | -0.16 | +46.7% | -44.8M |
| 2023 | 688.1M | — | -40.7M | -5.9% | -0.30 | -500.0% | -3.1M |
| 2022 | — | — | — | — | -0.05 | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 15 Dec 2023 | 5.87 | 6.00 | 5.65 | 5.69 | -0.70% | 135,600 | |
| 14 Dec 2023 | 5.67 | 5.92 | 5.58 | 5.73 | +1.24% | 31,100 | |
| 13 Dec 2023 | 5.63 | 5.75 | 5.42 | 5.66 | +0.71% | 29,400 | |
| 12 Dec 2023 | 5.76 | 5.92 | 5.61 | 5.62 | -0.18% | 11,000 | |
| 11 Dec 2023 | 5.51 | 5.73 | 5.51 | 5.63 | +1.26% | 30,000 | |
| 08 Dec 2023 | 5.56 | 5.69 | 5.50 | 5.56 | -0.71% | 16,500 | |
| 07 Dec 2023 | 5.86 | 5.86 | 5.53 | 5.60 | -1.41% | 13,700 | |
| 06 Dec 2023 | 5.86 | 5.96 | 5.63 | 5.68 | -1.22% | 12,900 | |
| 05 Dec 2023 | 5.99 | 5.99 | 5.62 | 5.75 | -3.52% | 46,900 | |
| 04 Dec 2023 | 5.87 | 6.00 | 5.60 | 5.96 | +1.02% | 67,000 | |
| 01 Dec 2023 | 5.83 | 5.96 | 5.83 | 5.90 | +0.51% | 21,700 | |
| 30 Nov 2023 | 6.01 | 6.07 | 5.82 | 5.87 | -0.51% | 14,300 | |
| 29 Nov 2023 | 5.90 | 6.08 | 5.81 | 5.90 | +2.43% | 15,400 | |
| 28 Nov 2023 | 5.71 | 6.10 | 5.64 | 5.76 | -0.69% | 15,100 | |
| 27 Nov 2023 | 5.88 | 6.35 | 5.73 | 5.80 | -2.52% | 28,900 | |
| 24 Nov 2023 | 5.60 | 5.97 | 5.51 | 5.95 | +7.40% | 8,500 | |
| 22 Nov 2023 | 5.33 | 5.59 | 5.17 | 5.54 | +5.32% | 8,500 | |
| 21 Nov 2023 | 5.75 | 5.75 | 5.16 | 5.26 | -9.31% | 21,700 | |
| 20 Nov 2023 | 5.63 | 6.00 | 5.63 | 5.80 | +1.40% | 16,200 | |
| 17 Nov 2023 | 5.62 | 5.90 | 5.50 | 5.72 | +3.72% | 42,300 | |
| 16 Nov 2023 | 5.59 | 5.60 | 5.29 | 5.52 | -2.39% | 9,400 | |
| 15 Nov 2023 | 6.27 | 6.27 | 5.61 | 5.65 | -9.89% | 38,600 | |
| 14 Nov 2023 | 5.91 | 6.27 | 5.77 | 6.27 | +11.17% | 39,700 | |
| 13 Nov 2023 | 5.56 | 5.70 | 5.34 | 5.64 | +1.62% | 12,200 | |
| 10 Nov 2023 | 5.52 | 5.55 | 5.28 | 5.55 | +1.83% | 16,100 |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- InnovAge Holding (INNV) Reaffirms 2027 Outlook Following Strong Quarter As Fair Value Stays In View (opens in a new tab) Simply Wall St. · 06 Nov 2026 15:15
- InnovAge (INNV) Q1 2027 Earnings Call Transcript (opens in a new tab) Motley Fool · 04 Nov 2026 15:44
- InnovAge Holding Corp. Q1 2027 Earnings Call Summary (opens in a new tab) Moby · 04 Nov 2026 13:30
- InnovAge Holding Corp (INNV) (Q1 2027) Earnings Call Highlights: Revenue Jumps 12% and Adjusted ... (opens in a new tab) GuruFocus.com · 04 Nov 2026 07:08
- What InnovAge (INNV) Said on Its Q1 Earnings Call (opens in a new tab) MarketBeat · 04 Nov 2026 01:14
- InnovAge Holding Corp. (INNV) Q1 2027 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 04 Nov 2026 00:25
- InnovAge Holding Corp. (INNV) Tops Q1 Earnings and Revenue Estimates (opens in a new tab) Zacks · 03 Nov 2026 23:55
- InnovAge Holding Corp (NASDAQ:INNV) EPS Beat Offset by In-Line Revenue and Below-Consensus Guidance (opens in a new tab) ChartMill · 03 Nov 2026 23:35
- InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2026 (opens in a new tab) 03 Nov 2026 21:05
- InnovAge Holding Q1 2027 Earnings Call Transcript (opens in a new tab) Benzinga · 03 Nov 2026 19:14
- InnovAge Holding Affirms FY2027 Sales Guidance of $1.050B-$1.085B vs $1.074B Est (opens in a new tab) Benzinga · 03 Nov 2026 17:08
- InnovAge Q1 EPS $0.14 Up From $0.06 YoY; Sales $264.76M Up From $236.11M YoY (opens in a new tab) Benzinga · 03 Nov 2026 17:08
- InnovAge Holding (INNV), Why Is It Getting Fresh Attention? (opens in a new tab) Simply Wall St. · 27 Sep 2026 11:08
- InnovAge (INNV) Reaches a 9.6% Adjusted EBITDA Margin. Can the PACE Recovery Last? (opens in a new tab) Insider Monkey · 11 Sep 2026 01:11
- InnovAge (INNV) Q4 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 09 Sep 2026 23:43
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 9.09 USD
- Market cap
- 1.2B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 21.5 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 6.6 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 13.3 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 7.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Thin interest cover: operating profit is only 1.4× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 149.5× | Weak | 31.09× |
| P/E (forward) | 17.94× | Fair | 14.98× |
| Price / book | 4.79× | Weak | 3.87× |
| Price / sales | 1.2× | Good | 3.42× |
| EV / EBITDA | 30.46× | Weak | 13.09× |
| Free cash flow yield | 5.6% | Good | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 68.4% | Good | 59.2% |
| Operating margin | 7.6% | Weak | 7.8% |
| Net margin | 0.9% | Weak | 3.4% |
| Return on equity | 4.4% | Weak | 5.7% |
| Return on assets | 2% | Weak | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 12.9% | Good | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.29× | Good | 0.46× |
| Net debt / EBITDA | -2.01× | Good | 1.48× |
| Interest cover | 1.36× | Weak | 3.26× |
| Current ratio | 1.16× | Fair | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow INNV and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.